Description Code
Atazanavir 300 mg + Ritonavir 100 mg
HIV, Pharmaceutical Products
Atazanavir 300 mg + Ritonavir 100 mg
Fixed-dose combination antiretroviral tablet combining Atazanavir 300 mg and Ritonavir 100 mg, used to treat HIV-1 infection by enhancing protease inhibitor efficacy.
Form: Film-coated tablet
Manufacturer: Cipla Ltd.
Country of Origin: India
| Composition | Atazanavir 300 mg + Ritonavir 100 mg |
|---|---|
| Pack Size | Strip of 30 tablets |
| Form | Film-coated tablet |
| Administration Route | Oral, with food to improve absorption |
| Dosage Regimen | as prescribed, One tablet once daily |
| Usage Indications | HIV-1 infection (as part of ART) |
| Country of Origin | India |
| Manufacturer | Cipla Ltd. |
| Prescription Status | Rx required |
| Storage Conditions | Store below 30 °C; protect from moisture |
| Shelf Life | 24 months (typical) |
| Common Side Effects | abdominal pain, diarrhea, elevated bilirubin, headache, Jaundice, nausea |
| Precautions | Check bilirubin levels; avoid acid-reducing agents around dose; counsel on rash and kidney stones |






Reviews
There are no reviews yet.